Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial
| Image |  |
|---|---|
| Description | scientific article published on 07 December 2018 |
| Author/s |
author: Alessandra Gennari Oriana Nanni |
| Publication date | December 7, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |